According to Nabriva Therapeutics 's latest financial reports the company's current revenue (TTM) is $35.58 M. In 2022 the company made a revenue of $35.66 M an increase over the years 2021 revenue that were of $27.21 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $35.58 M | -0.22% |
2022 | $35.66 M | 31.06% |
2021 | $27.21 M | 850.28% |
2020 | $2.86 M | -63.04% |
2019 | $7.74 M | 19.2% |
2018 | $6.5 M | |
2017 | N/A | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |